Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 26% ± 6% | |
| oligodendrocyte precursor cell | 5 studies | 27% ± 11% | |
| glutamatergic neuron | 4 studies | 37% ± 9% | |
| GABAergic neuron | 3 studies | 27% ± 5% | |
| macrophage | 3 studies | 18% ± 2% | |
| basal cell | 3 studies | 25% ± 8% | |
| neuron | 3 studies | 26% ± 10% | |
| endothelial cell | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 28% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 4134.75 | 966 / 966 | 100% | 15.44 | 527 / 527 |
| prostate | 100% | 3187.78 | 245 / 245 | 100% | 21.55 | 502 / 502 |
| stomach | 100% | 2529.43 | 359 / 359 | 100% | 14.22 | 286 / 286 |
| thymus | 100% | 3645.02 | 653 / 653 | 100% | 19.14 | 605 / 605 |
| brain | 100% | 2890.92 | 2640 / 2642 | 100% | 20.30 | 705 / 705 |
| breast | 100% | 3143.96 | 459 / 459 | 100% | 22.35 | 1117 / 1118 |
| bladder | 100% | 3040.62 | 21 / 21 | 100% | 14.16 | 503 / 504 |
| uterus | 100% | 2883.66 | 170 / 170 | 100% | 15.70 | 457 / 459 |
| esophagus | 100% | 2812.73 | 1445 / 1445 | 99% | 13.40 | 182 / 183 |
| pancreas | 100% | 1923.06 | 328 / 328 | 99% | 13.10 | 177 / 178 |
| kidney | 100% | 2795.48 | 89 / 89 | 99% | 14.79 | 895 / 901 |
| lung | 100% | 2806.87 | 577 / 578 | 99% | 13.84 | 1149 / 1155 |
| ovary | 100% | 3712.63 | 180 / 180 | 99% | 12.62 | 426 / 430 |
| skin | 100% | 2540.84 | 1808 / 1809 | 99% | 19.38 | 466 / 472 |
| adrenal gland | 100% | 2071.90 | 258 / 258 | 98% | 19.85 | 226 / 230 |
| liver | 100% | 1888.31 | 226 / 226 | 95% | 8.63 | 385 / 406 |
| adipose | 100% | 2809.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.95 | 29 / 29 |
| muscle | 100% | 3689.48 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2914.86 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 18.94 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.85 | 1 / 1 |
| heart | 100% | 2643.77 | 859 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1721.24 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 15.78 | 77 / 80 |
| peripheral blood | 80% | 1295.14 | 743 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045599 | Biological process | negative regulation of fat cell differentiation |
| GO_0008150 | Biological process | biological_process |
| GO_0006693 | Biological process | prostaglandin metabolic process |
| GO_0005777 | Cellular component | peroxisome |
| GO_0036132 | Molecular function | 13-prostaglandin reductase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0003674 | Molecular function | molecular_function |
| GO_0047522 | Molecular function | 15-oxoprostaglandin 13-oxidase activity |
| Gene name | PTGR3 |
| Protein name | ZADH2 protein Prostaglandin reductase 3 (PRG-3) (EC 1.3.1.48) (Zinc-binding alcohol dehydrogenase domain-containing protein 2) Prostaglandin reductase 3 |
| Synonyms | ZADH2 |
| Description | FUNCTION: Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-keto-PGE1, 15-keto-PGE2, 15-keto-PGE1-alpha and 15-keto-PGE2-alpha with highest efficiency towards 15-keto-PGE2-alpha. Overexpression represses transcriptional activity of PPARG and inhibits adipocyte differentiation. . |
| Accessions | ENST00000537114.2 [Q8N4Q0-2] Q4G1C4 ENST00000322342.4 [Q8N4Q0-1] Q8N4Q0 J3QQQ7 ENST00000581620.1 J3KTQ8 ENST00000582437.1 |
